Category: news

– Study results across 17 medicines reflect our commitment to personalized care with advances in targeted therapies, immunotherapy, and diagnostics,…

GAITHERSBURG, Md.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/CRO?src=hash" target="_blank"gt;#CROlt;/agt;–Smithers Avanza, a contract research organization (CRO) specializing in supporting development of large molecule therapeutics, announced…

CHICAGO & CAMBRIDGE, Mass.–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/DigitalDrugDesign?src=hash" target="_blank"gt;#DigitalDrugDesignlt;/agt;–Exicure, Inc. (OTCQB: XCUR), the pioneer in gene regulatory and immunotherapeutic drugs utilizing spherical…

Positive OpRegen® Data Presented at Association for Research in Vision and Ophthalmology Annual Meeting Announced Issuance of New Patent for…

– Top-line Data from INVICTUS Pivotal Phase 3 Clinical Study of Ripretinib in Fourth-line and Fourth-line Plus GIST Patients Expected…

— Initiated Screening of Participants to Enroll in the PHYOX™2 Phase 2 Pivotal Trial of DCR-PHXC for the Treatment of…

Conference call begins today at 4:30 p.m. Eastern time EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company…

Company Reports $1.7 Million in Net Product Revenues from COPIKTRA™; Issues Product Revenue Guidance for 2019 Cash, Cash Equivalents and…

– Company will host a conference call and webcast at 5:00 pm ET today – CAMBRIDGE, Mass.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24SYBX&src=ctag" target="_blank"gt;$SYBXlt;/agt;…

– Conference Call Today at 4:30 p.m. ET – SEATTLE–(BUSINESS WIRE)–Omeros Corporation (NASDAQ: OMER), a commercial-stage biopharmaceutical company committed to…